Commercialising Scientific Advice for MHRA

Access full document

Details

Contract Title:Commercialising Scientific Advice for MHRA
Published Date:May 22, 2026
Notice Type:Award (ContractAwardNotice)
Value Banding:High Value
Delivery Point:United Kingdom

Description:

The Medicines and Healthcare Products Regulatory Agency requires consultancy to support the MHRA in responding to increasing demand, improving service quality and predictability, and ensuring the Scientific Advice offer remains competitive, sustainable, and aligned with the MHRA 2030 Strategy. The Deliverables are as follows: • Description of MHRA's unique strengths and market context; 5-10 critical hypotheses regarding potential demand and operational requirements for the MHRA to commercialise...


Back to search results